Brief: Xspray Q1 Revenue SEK 0

Xspray Pharma publ AB

08/05/2024 07:00

May 08 (Reuters) - Xspray Q1 adjusted EPS SEK -2.17.
* Q1 adjusted free cash flow SEK -55.311 million
* Q1 pretax profit SEK -67.781 million